CD274 and squamous cell carcinoma: This is in line with other studies reporting the effect of cisplatin as an enhancer of PD-L1 expression on squamous and non-squamous cell cancer in other organs [56,57,58,59,60,61], and our result may be the first quantitative evaluation of the effect of therapy schemes with a platinum agent on PD-L1 expression.